BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Moehler M, Frings C, Mueller A, Gockel I, Schimanski CC, Biesterfeld S, Galle PR, Holtmann MH. VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab. World J Gastroenterol 2008; 14(26): 4156-4167 [PMID: 18636661 DOI: 10.3748/wjg.14.4156]
URL: https://www.wjgnet.com/1007-9327/full/v14/i26/4156.htm
Number Citing Articles
1
Taner Babacan, Ibrahim Halil Turkbeyler, Muhammet Sait Dag, Ismail Dilli, Ozan Balakan, Kadri Altundag. Cetuximab-induced esophageal ulcer: the first report in literatureLibyan Journal of Medicine 2014; 9(1) doi: 10.3402/ljm.v9.23723
2
M. Moehler, A. Mueller, T. Trarbach, F. Lordick, T. Seufferlein, S. Kubicka, M. Geißler, S. Schwarz, P.R. Galle, S. Kanzler. Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II studyAnnals of Oncology 2011; 22(6): 1358 doi: 10.1093/annonc/mdq591
3
Jennifer Ose, Biljana Gigic, Sheetal Hardikar, Tengda Lin, Caroline Himbert, Christy A. Warby, Anita R. Peoples, Clara L. Lindley, Juergen Boehm, Petra Schrotz-King, Jane C. Figueiredo, Adetunji T. Toriola, Erin M. Siegel, Christopher I. Li, Alexis Ulrich, Martin Schneider, David Shibata, Cornelia M. Ulrich. Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare StudyCancer Epidemiology, Biomarkers & Prevention 2022; 31(8): 1650 doi: 10.1158/1055-9965.EPI-22-0092
4
Ying-Bo Li, Zhong-Qing Wang, Xu Yan, Mei-Wan Chen, Jiao-Lin Bao, Guo-Sheng Wu, Ze-Mei Ge, De-Min Zhou, Yi-Tao Wang, Run-Tao Li. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activitiesCancer Letters 2013; 340(1): 88 doi: 10.1016/j.canlet.2013.07.005
5
Caren Jayasinghe, Nektaria Simiantonaki, Sylvia Habedank, Charles James Kirkpatrick. The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancerJournal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0162-5
6
Pithi Chanvorachote, Varisa Pongrakhananon, Hasseri Halim. Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cellsMolecular and Cellular Biochemistry 2015; 399(1-2): 291 doi: 10.1007/s11010-014-2255-4
7
Ivo Stárek, Richard Salzman, Ladislava Kučerová, Alena Skálová, Lukáš Hauer. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinomaPathology - Research and Practice 2015; 211(10): 759 doi: 10.1016/j.prp.2015.07.001
8
E. Jubeli, N. Yagoubi, F. Pascale, L. Bédouet, K. Slimani, D. Labarre, J.P. Saint-Maurice, A. Laurent, L. Moine. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformationsEuropean Journal of Pharmaceutics and Biopharmaceutics 2015; 96: 396 doi: 10.1016/j.ejpb.2015.09.006
9
Manuela Eppenberger, Inti Zlobec, Daniel Baumhoer, Luigi Terracciano, Alessandro Lugli. Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancerBMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-93
10
Camille Ettelaie, Donna Fountain, Mary Elizabeth W. Collier, Azza M. ElKeeb, Yu Pei Xiao, Anthony Maraveyas. Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κBBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011; 1812(12): 1591 doi: 10.1016/j.bbadis.2011.09.007
11
Thomas Thomaidis, Annett Maderer, Andrea Formentini, Susanne Bauer, Mario Trautmann, Michael Schwarz, Wiebke Neumann, Jens Martin Kittner, Arno Schad, Karl-Heinrich Link, Johannes Wilhelm Rey, Arndt Weinmann, Arthur Hoffman, Peter Robert Galle, Marko Kornmann, Markus Moehler. Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trialJournal of Experimental & Clinical Cancer Research 2014; 33(1) doi: 10.1186/s13046-014-0083-8
12
Connie I. Diakos, Kellie A. Charles, Wei Chua, Viive M. Howell, Stephen J. Clarke. Biomarkers in Cancer2014; : 1 doi: 10.1007/978-94-007-7744-6_1-1
13
Chunhui Zhang, Li Hao, Liang Wang, Yichuan Xiao, Hailiang Ge, Zhenya Zhu, Yunbao Luo, Yi Zhang, Yanyun Zhang. Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancerBMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-184
14
Robert Coleman, Luis Costa, Fred Saad, Richard Cook, Peyman Hadji, Evangelos Terpos, Patrick Garnero, Janet Brown, Jean-Jacques Body, Matthew Smith, Ker-Ai Lee, Pierre Major, Meletios Dimopoulos, Allan Lipton. Consensus on the utility of bone markers in the malignant bone disease settingCritical Reviews in Oncology/Hematology 2011; 80(3): 411 doi: 10.1016/j.critrevonc.2011.02.005
15
Annett Maderer, Stanislav Plutizki, Jan-Peter Kramb, Katrin Göpfert, Monika Linnig, Katrin Khillimberger, Christopher Ganser, Eva Lauermann, Gerd Dannhardt, Peter R. Galle, Markus Moehler. Moguntinones—New Selective Inhibitors for the Treatment of Human Colorectal CancerMolecular Cancer Therapeutics 2014; 13(6): 1399 doi: 10.1158/1535-7163.MCT-13-0224
16
Orestis Lyros, Annett Mueller, Florian Heidel, Carl C. Schimanski, Ines Gockel, Peter R. Galle, Hauke Lang, Markus Moehler. Analysis of anti‐proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi‐receptor tyrosine kinase pathwaysInternational Journal of Cancer 2010; 127(5): 1197 doi: 10.1002/ijc.25137
17
Lixia He, Junyong He, Xia Zhao. Expression of VEGF‐D in epithelial ovarian cancer and its relationship to lymphatic metastasisAsia-Pacific Journal of Clinical Oncology 2016; 12(1) doi: 10.1111/ajco.12086
18
Carl C. Schimanski, Friederike Schlaegel, Mareike Jordan, Markus Moehler, George Sgourakis, Daniel G. Drescher, Peter R. Galle, Hauke Lang, Ines Gockel. VEGF‐D Correlates with Metastatic Disease in Gastric Cancer Patients Undergoing SurgeryWorld Journal of Surgery 2011; 35(5): 1010 doi: 10.1007/s00268-011-1041-7
19
M. Pia Morelli, Amy M. Brown, Todd M. Pitts, John J. Tentler, Fortunato Ciardiello, Anderson Ryan, Juliane M. Jürgensmeier, S. Gail Eckhardt. Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell linesMolecular Cancer Therapeutics 2009; 8(9): 2546 doi: 10.1158/1535-7163.MCT-09-0380
20
Aya M. A. Elsayed, Mariam Oweda, Asmaa M. Abushady, Maha Alhelf, Shaimaa R. M. Khalil, Mohamed S. Tawfik, Walid Al-Atabany, Mohamed El-Hadidi. Identification of Differentially Expressed Genes in Human Colorectal Cancer Using RNASeq Data Validated on the Molecular Level with Real-Time PCRBiochemical Genetics 2024; 62(4): 3260 doi: 10.1007/s10528-023-10593-5
21
Connie I. Diakos, Kellie A. Charles, Wei Chua, Viive M. Howell, Stephen J. Clarke. Biomarkers in CancerBiomarkers in Disease: Methods, Discoveries and Applications 2015; : 601 doi: 10.1007/978-94-007-7681-4_1
22
Stephen J. Clarke, Christos S. Karapetis, Peter Gibbs, Nick Pavlakis, Jayesh Desai, Michael Michael, Niall C. Tebbutt, Tim J. Price, Josep Tabernero. Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factorsCritical Reviews in Oncology/Hematology 2013; 85(2): 121 doi: 10.1016/j.critrevonc.2012.06.001
23
Steven A. Stacker, Steven P. Williams, Tara Karnezis, Ramin Shayan, Stephen B. Fox, Marc G. Achen. Lymphangiogenesis and lymphatic vessel remodelling in cancerNature Reviews Cancer 2014; 14(3): 159 doi: 10.1038/nrc3677
24
V. Moreno García, J. F. Batlle, E. Casado, E. Burgos, J. de Castro, C. Belda, J. Barriuso, J. J. Sánchez, M. Á. García-Cabezas, M. González-Barón, P. Cejas. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapyColorectal Disease 2011; 13(9): 989 doi: 10.1111/j.1463-1318.2010.02386.x
25
Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, Janis Kany, Claudia Pauligk, Kristina Steinmetz, Arno Schad, Ralf Hofheinz, Harald Schmalenberg, Nils Homann, Peter Robert Galle, Markus Moehler. VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-476
26
M. Moehler, A. Mueller, J.T. Hartmann, M.P. Ebert, S.E. Al-Batran, P. Reimer, M. Weihrauch, F. Lordick, T. Trarbach, S. Biesterfeld, M. Kabisch, D. Wachtlin, P.R. Galle. An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancerEuropean Journal of Cancer 2011; 47(10): 1511 doi: 10.1016/j.ejca.2011.04.006
27
Ping Yan, Hui Gong, Xiaoyan Zhai, Yi Feng, Jun Wu, Sheng He, Jian Guo, Xiaoxia Wang, Rui Guo, Jun Xie, Ren-Ke Li. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 PathwayThe American Journal of Pathology 2016; 186(4): 1015 doi: 10.1016/j.ajpath.2015.11.012
28
Jiri Hoza, Richard Salzman, Tomas Bakaj, Ladislava Kucerova, Ivo Starek. Comparison of lymphatic vessel density and expression of VEGF-C and VEGF-D lymphangiogenic factors in Warthin's tumours and oncocytic adenomasBiomedical Papers 2018; 162(1): 47 doi: 10.5507/bp.2017.048
29
J. Nolde, C. deWit, E. Schloericke, H.-P. Bruch, T. Laubert. Regulation of tumor growth and angiogenesis in colorectal cancerEuropean Surgery 2012; 44(5): 336 doi: 10.1007/s10353-012-0160-1
30
Massimiliano Berretta, Lara Alessandrini, Chiara De Divitiis, Guglielmo Nasti, Arben Lleshi, Raffaele Di Francia, Gaetano Facchini, Carla Cavaliere, Carlo Buonerba, Vincenzo Canzonieri. Serum and tissue markers in colorectal cancer: State of artCritical Reviews in Oncology/Hematology 2017; 111: 103 doi: 10.1016/j.critrevonc.2017.01.007
31
Hui Ying, Ren-Jun Huang, Xiao-Min Jing, Yan Li, Qun-Qiu Tong. Effect of cetuximab plus FOLFOX4 regimen on clinical outcomes in advanced gastric carcinoma patients receiving evidence-based careWorld Journal of Clinical Cases 2024; 12(18): 3360-3367 doi: 10.12998/wjcc.v12.i18.3360